Elan Pharmaceuticals

Perrigo Company PLC (NYSE: PRGO) disclosed a possible $1.9 billion tax liability after Thursday's close, prompting a plunge in share price. The company plans to appeal Irish tax authorities on behalf of its Elan Pharmaceuticals, whose Tysabri intellectual property and Biogen Idec assets were...